{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T16:04:41Z","timestamp":1783181081448,"version":"3.54.6"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T00:00:00Z","timestamp":1683676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hematopoietic malignancies are extremely common in pet dogs and represent nearly 30% of the malignancies diagnosed in this population each year. Clinicians commonly use existing tools such as physical exam findings, radiographs, ultrasound and baseline blood work to monitor these patients for treatment response and remission. Circulating biomarkers, such as prostate specific antigen or carcinoembryonic antigen, can be useful tools for monitoring treatment response and remission status in human cancer patients. To date, there has a been a lack of useful circulating biomarkers available to veterinary oncology patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Circulating plasma nucleosome concentrations were evaluated at diagnosis, throughout treatment and during remission monitoring for 40 dogs with lymphoma, acute myelogenous leukemia and multiple myeloma. Additionally, C-reactive protein and thymidine kinase-1 levels were recorded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Plasma nucleosome concentrations were significantly higher at diagnosis and progressive disease than they were when dogs were in remission. All but two dogs had plasma nucleosome concentrations that returned to the low range during treatment. These two dogs had the shortest progression free and overall survival times. Dogs with the highest plasma nucleosome concentrations had a significantly shorter first progression free survival than dogs with lower plasma nucleosome concentrations at diagnosis. Plasma nucleosome concentrations correlated better with disease response and progression than either thymidine kinase or C reactive protein.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Plasma nucleosome concentrations can be a useful tool for treatment monitoring and disease progression in dogs with hematopoietic malignancies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0281796","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T13:37:21Z","timestamp":1683725841000},"page":"e0281796","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Monitoring plasma nucleosome concentrations to measure disease response and progression in dogs with hematopoietic malignancies"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6489-8468","authenticated-orcid":true,"given":"Heather","family":"Wilson-Robles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Warry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasha","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Jarvis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marielle","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Valery","family":"Turatsinze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa K.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Thomas","family":"Butera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetan","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,5,10]]},"reference":[{"key":"pone.0281796.ref001","volume-title":"Withrow & MacEwen\u2019s small animal clinical oncology","author":"SJ Withrow"},{"issue":"1","key":"pone.0281796.ref002","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12917-021-02991-x","article-title":"Characterizing circulating nucleosomes in the plasma of dogs with lymphoma","volume":"17","author":"C Dolan","year":"2021","journal-title":"BMC Vet Res"},{"issue":"1","key":"pone.0281796.ref003","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12917-021-02934-6","article-title":"Characterizing circulating nucleosomes in the plasma of dogs with hemangiosarcoma","volume":"17","author":"H Wilson-Robles","year":"2021","journal-title":"BMC Vet Res"},{"key":"pone.0281796.ref004","doi-asserted-by":"crossref","first-page":"664718","DOI":"10.3389\/fvets.2021.664718","article-title":"Horizons in Veterinary Precision Oncology: Fundamentals of Cancer Genomics and Applications of Liquid Biopsy for the Detection, Characterization, and Management of Cancer in Dogs","volume":"8","author":"J Chibuk","year":"2021","journal-title":"Front Vet Sci"},{"key":"pone.0281796.ref005","doi-asserted-by":"crossref","first-page":"704835","DOI":"10.3389\/fvets.2021.704835","article-title":"Blood-Based Liquid Biopsy for Comprehensive Cancer Genomic Profiling Using Next-Generation Sequencing: An Emerging Paradigm for Non-invasive Cancer Detection and Management in Dogs","volume":"8","author":"KM Kruglyak","year":"2021","journal-title":"Front Vet Sci"},{"issue":"12","key":"pone.0281796.ref006","article-title":"Predicting Dynamic Clinical Outcomes of the Chemotherapy for Canine Lymphoma Patients Using a Machine Learning Model","volume":"8","author":"J Koo","year":"2021","journal-title":"Vet Sci"},{"issue":"1","key":"pone.0281796.ref007","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12894-022-01145-x","article-title":"Adjusting the duration of androgen deprivation therapy (ADT) based on nadir PSA for high risk localized prostate cancer patients treated with definitive external beam radiation therapy and ADT","volume":"22","author":"Z Ayoub","year":"2022","journal-title":"BMC Urol"},{"issue":"23","key":"pone.0281796.ref008","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1056\/NEJMoa2209454","article-title":"Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only","volume":"387","author":"J Hugosson","year":"2022","journal-title":"N Engl J Med"},{"issue":"11","key":"pone.0281796.ref009","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.4240\/wjgs.v14.i11.1272","article-title":"Assessment of tumor markers CA 19\u20139, CEA, CA 125, and CA 242 for the early diagnosis and prognosis prediction of gallbladder cancer","volume":"14","author":"SR Sinha","year":"2022","journal-title":"World J Gastrointest Surg"},{"key":"pone.0281796.ref010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.33393\/jcb.2022.2446","article-title":"Diagnostic impact of CEA and CA 15\u20133 on chemotherapy monitoring of breast cancer patients","volume":"11","author":"D. Hasan","year":"2022","journal-title":"J Circ Biomark"},{"issue":"33","key":"pone.0281796.ref011","doi-asserted-by":"crossref","first-page":"8518","DOI":"10.1016\/j.biomaterials.2011.07.048","article-title":"Identification of a peptide that interacts with Nestin protein expressed in brain cancer stem cells","volume":"32","author":"S Beck","year":"2011","journal-title":"Biomaterials"},{"issue":"1","key":"pone.0281796.ref012","first-page":"34","article-title":"Lymphoma: Diagnosis and Treatment","volume":"101","author":"WD Lewis","year":"2020","journal-title":"Am Fam Physician"},{"issue":"1","key":"pone.0281796.ref013","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12916-022-02562-3","article-title":"Clinical implications of circulating tumor DNA in predicting the outcome of diffuse large B cell lymphoma patients receiving first-line therapy","volume":"20","author":"M Li","year":"2022","journal-title":"BMC Med"},{"issue":"12","key":"pone.0281796.ref014","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1080\/10428194.2022.2103808","article-title":"Prognostic value of minimal residual disease among patients with classical Hodgkin lymphoma undergoing autologous stem cell transplantation","volume":"63","author":"E Taranto","year":"2022","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"pone.0281796.ref015","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1182\/bloodadvances.2021006415","article-title":"Risk profiling of patients with relapsed\/refractory diffuse large B-cell lymphoma by measuring circulating tumor DNA","volume":"6","author":"AF Herrera","year":"2022","journal-title":"Blood Adv"},{"issue":"11","key":"pone.0281796.ref016","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1182\/bloodadvances.2020001637","article-title":"Liquid biopsy in extranodal NK\/T-cell lymphoma: a prospective analysis of cell-free DNA genotyping and monitoring","volume":"5","author":"F Qi","year":"2021","journal-title":"Blood Adv"},{"issue":"27","key":"pone.0281796.ref017","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1200\/JCO.21.00377","article-title":"Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional Trial","volume":"39","author":"MJ Frank","year":"2021","journal-title":"J Clin Oncol"},{"key":"pone.0281796.ref018","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13148-017-0351-5","article-title":"Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer","volume":"9","author":"JF Rahier","year":"2017","journal-title":"Clin Epigenetics"},{"issue":"12","key":"pone.0281796.ref019","doi-asserted-by":"crossref","first-page":"e2518","DOI":"10.1038\/cddis.2016.410","article-title":"Extracellular histones, cell-free DNA, or nucleosomes: differences in immunostimulation","volume":"7","author":"G Marsman","year":"2016","journal-title":"Cell Death Dis"},{"issue":"11","key":"pone.0281796.ref020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115578","article-title":"Sophisticated Conversations between Chromatin and Chromatin Remodelers, and Dissonances in Cancer","volume":"22","author":"CR Clapier","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"6","key":"pone.0281796.ref021","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1182\/blood-2002-10-3312","article-title":"Role of macrophages in the generation of circulating blood nucleosomes from dead and dying cells","volume":"102","author":"N Jiang","year":"2003","journal-title":"Blood"},{"issue":"3","key":"pone.0281796.ref022","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.156.3.1151","article-title":"Blood clearance kinetics and liver uptake of mononucleosomes in mice","volume":"156","author":"VJ Gauthier","year":"1996","journal-title":"J Immunol"},{"key":"pone.0281796.ref023","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-2249.1992.tb05831.x","article-title":"Haemodialysis as a model for studying endogenous plasma DNA: oligonucleosome-like structure and clearance","volume":"90","author":"P Rumore","year":"1992","journal-title":"Clin. Exp. Immunol"},{"issue":"1","key":"pone.0281796.ref024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408360802485875","article-title":"Clinical use of circulating nucleosomes","volume":"46","author":"S Holdenrieder","year":"2009","journal-title":"Crit Rev Clin Lab Sci"},{"key":"pone.0281796.ref025","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1196\/annals.1448.012","article-title":"Clinical relevance of circulating nucleosomes in cancer","volume":"1137","author":"S Holdenrieder","year":"2008","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"pone.0281796.ref026","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/vco.12032","article-title":"Response evaluation criteria for solid tumours in dogs (v1.0): a Veterinary Cooperative Oncology Group (VCOG) consensus document","volume":"13","author":"SM Nguyen","year":"2015","journal-title":"Vet Comp Oncol"},{"issue":"8","key":"pone.0281796.ref027","doi-asserted-by":"crossref","first-page":"e0236228","DOI":"10.1371\/journal.pone.0236228","article-title":"Evaluation of nucleosome concentrations in healthy dogs and dogs with cancer","volume":"15","author":"H Wilson-Robles","year":"2020","journal-title":"PLoS One"},{"issue":"19","key":"pone.0281796.ref028","first-page":"10007","article-title":"Cancer-associated mutations of histones H2B, H3.1 and H2A.Z.1 affect the structure and stability of the nucleosome","volume":"46","author":"Y Arimura","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"pone.0281796.ref029","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/cncr.11882","article-title":"Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management","volume":"100","author":"J Crawford","year":"2004","journal-title":"Cancer"},{"key":"pone.0281796.ref030","unstructured":"STANFORD SN RC, ROY A, HARRIS B, ASHTON T, MANGLES S, EVERINGTON T, et al., editor Identifying tools to track hypercoagulability in COVID-19 patients: Exploring global haemostasis (ROTEM) and neutrophil extracellular traps (NETs) immunoassays. ISTH virtual conference; 2021; Philadelphia, PA."},{"issue":"2","key":"pone.0281796.ref031","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/1097-0215(20010320)95:2<114::AID-IJC1020>3.0.CO;2-Q","article-title":"Nucleosomes in serum of patients with benign and malignant diseases","volume":"95","author":"S Holdenrieder","year":"2001","journal-title":"Int J Cancer"},{"issue":"3","key":"pone.0281796.ref032","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/j.tcam.2009.03.003","article-title":"Lymphoma: which chemotherapy protocol and why?","volume":"24","author":"R. Chun","year":"2009","journal-title":"Top Companion Anim Med"},{"issue":"6","key":"pone.0281796.ref033","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrc3066","article-title":"Cell-free nucleic acids as biomarkers in cancer patients","volume":"11","author":"H Schwarzenbach","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"pone.0281796.ref034","doi-asserted-by":"crossref","first-page":"18925","DOI":"10.3390\/ijms140918925","article-title":"The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients","volume":"14","author":"YI Elshimali","year":"2013","journal-title":"Int J Mol Sci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0281796","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T13:37:59Z","timestamp":1683725879000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0281796"}},"subtitle":[],"editor":[{"given":"Douglas H.","family":"Thamm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,5,10]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0281796","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.02.02.526779","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,10]]}}}